Even if they don’t have disease relapses, people with neuromyelitis optica spectrum disorder (NMOSD) tend to experience abnormal atrophy, or shrinkage, of the spinal cord over time, a new study shows. According to the researchers, “spinal cord involvement … accounts for significant disability in up to 80% of patients…
Discussion
I hate complaining. Truly. Deep in my soul, I believe in powering through, staying positive, and not becoming “that person” whose personality is just one long sigh. Victim mentality? Not my brand. I like to think I’m more of a “grit, grace, and decent hair day” kind of person. But…
MIL62, an injection therapy approved exclusively in China for neuromyelitis optica spectrum disorder (NMOSD), was found to keep most NMOSD patients free of relapses for up to two years, while being generally safe and well tolerated. That’s according to data from the Phase 1b portion of a single-center…
NMOSD is a progressive autoimmune disease where the immune system mistakenly attacks nerve cells, affecting the nervous system. Learn more about the disease here.
Scientists do not know the exact underlying cause of NMOSD. Self-reactive antibodies that target AQP4 are known to play a major role. Learn more about what causes the disease here.
When the disease affects the optic nerve (optic neuritis), it can result in pain inside the eye and possibly blurry vision or vision loss. Learn more about the symptoms of the disease here.
Get regular updates to your inbox.
